Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130.
about
Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinaseThe origins of cachexia in acute and chronic inflammatory diseases.FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor modelSelective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery.The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model.Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomas exhibit high (18)F-fludeoxyglucose uptake associated with glucose-6-phosphate transporter inactivation.Alteration of enzyme function of the type II hexokinase C-terminal half on replacements of restricted regions by corresponding regions of glucokinase.Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells.Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate.Hexokinase II in CD133+ and CD133- hepatoma BEL-7402 Cells.Characterization of porin isoforms expressed in tumor cells.Glucose catabolism in cancer cells: regulation of the Type II hexokinase promoter by glucose and cyclic AMP.Microheterogeneity of cytosolic and membrane-bound hexokinase II in Morris hepatoma 3924A.Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions.Glucose metabolism in cancer: importance of transcription factor-DNA interactions within a short segment of the proximal region og the type II hexokinase promoter.Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II.
P2860
Q28115329-42134FB1-3411-46B3-961A-C20854A409EEQ36378758-B6BFACB2-D2B8-4848-A724-42C9AE41A92DQ37063643-22A7BBD8-D867-4C1F-932A-9F2EC0DC8A07Q37353096-900D41C2-312D-4AFB-B28A-8BD63BAF9ABBQ37406500-79D4F2A8-E118-4317-9FB8-024F61352F2EQ37600943-43BE4EBD-EE88-4CCC-929B-E4733144EB8DQ38356377-5CE2E343-E51A-4E59-8521-A0368DC85704Q38480518-0D2FBEF0-D079-4F99-8D9A-F708E5E342CBQ39402922-0BB31A6B-271F-41E0-A4F5-2F02300035FEQ39475757-B35D373A-1FD4-4B13-BB93-F5B6AB1BBA2EQ40853637-A237653F-7D9E-486B-88F9-8D40B279B75DQ41199416-8F9CF496-978C-4A26-80F7-96B569CFF7C3Q41437622-ECBA76AD-74D8-4CF2-B038-365A32F51322Q43738168-FCE409B9-E3A7-4022-BF90-C36E17E61BB0Q44534309-EBB92C70-302E-4725-B105-A7D570191025Q45144348-CDC0EC7B-D32A-40F4-9DCD-03E2D8AC5693
P2860
Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130.
@en
type
label
Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130.
@en
prefLabel
Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130.
@en
P2093
P2860
P1433
P1476
Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130.
@en
P2093
P2860
P356
10.1016/0014-5793(91)81102-E
P407
P577
1991-10-01T00:00:00Z